Global Metabolic Disorder Therapeutics Market Report By Product (Metachromatic Leukodystrophy, Globoid Leukodystrophy, Hepatic Encephalopathy, And Others), Disease (Diabetes, Obesity, Hypercholesterolemia, And Lysosomal Storage Diseases), And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210578
January 2020
Report Formats:

As per this study the Global Metabolic Disorder Therapeutics Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Metabolism is a process in a digestive system where the food is broken down into glucose, amino acids, and fatty acids. A metabolic disorder is a condition when the body is unable to process metabolism and it can be caused due to unhealthy eating lifestyle. A metabolic disorder is either inherited genetically or acquired during the lifetime. Some metabolic disorders show mild symptoms that can be managed with slight medication whereas high symptoms such as breathing problems, organ failures, diabetes and others can be life-threatening. The treatment for this disorder can be done by enzyme replacement therapy, drug therapy, and others through oral and other administrations.
 
Market Dynamics
 
The rising incidences of obesity, diabetes and high cholesterol among the population is fueling the global metabolism market growth. Also, an increasing prevalence of unhealthy lifestyle diseases which leads to various digestive issues is also stimulating the market growth. On the flip side, the high cost of treatment for metabolic disorder is expected to restrain market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of metabolic disorder therapeutics.
 
Market Segmentation
 
The broad metabolic disorder therapeutics market has been sub-grouped into product and disease. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Metachromatic Leukodystrophy
  • Globoid Leukodystrophy
  • Hepatic Encephalopathy
  • Others
 
By Disease
  • Diabetes
  • Obesity
  • Hypercholesterolemia
  • Lysosomal Storage Diseases
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for metabolic disorder therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Metabolic Disorder Therapeutics Market By Revenue (USD MN)



The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Metabolic Disorder Therapeutics market include AbbVie Inc., Actelion Pharmaceuticals Ltd., AstraZeneca, Biocon, Boehringer Ingelheim, CymaBay Therapeutics, Eli Lilly and Company, Merck KgaA, Novo Nordisk, and Sanofi. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Metabolic Disorder Therapeutics Market
       2.2. Global Metabolic Disorder Therapeutics Market Snapshot
 
3 . METABOLIC DISORDER THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Metabolic Disorder Therapeutics Market
       3.3. Market Restraints of Metabolic Disorder Therapeutics Market
       3.4. Opportunities of Metabolic Disorder Therapeutics Market
       3.5. Trends of Metabolic Disorder Therapeutics Market
       3.6. Porter’s Five Force Analysis of Metabolic Disorder Therapeutics Market
       3.7. Metabolic Disorder Therapeutics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by By Product
           3.7.2 Market Attractive Analysis by By Disease
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Metabolic Disorder Therapeutics Value Chain Analysis
       4.2. Metabolic Disorder Therapeutics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Metabolic Disorder Therapeutics Raw Material Manufactures List
           4.2.3. Price Trend of Metabolic Disorder Therapeutics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL METABOLIC DISORDER THERAPEUTICS MARKET ANALYSIS BY BY PRODUCT
       5.1 Overview by By Product
       5.2 Global Metabolic Disorder Therapeutics Market Analysis by By Product
       5.3 Market Analysis of Metachromatic Leukodystrophy by Regions
       5.4 Market Analysis of Globoid Leukodystrophy by Regions
       5.5 Market Analysis of Hepatic Encephalopathy by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL METABOLIC DISORDER THERAPEUTICS MARKET ANALYSIS BY BY DISEASE
       6.1 Overview by By Disease
       6.2 Global Metabolic Disorder Therapeutics Market Analysis by By Disease
       6.3 Market Analysis of Diabetes by Regions
       6.4 Market Analysis of Obesity by Regions
       6.5 Market Analysis of Hypercholesterolemia by Regions
       6.6 Market Analysis of Lysosomal Storage Diseases by Regions
 
7 . GLOBAL METABOLIC DISORDER THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Metabolic Disorder Therapeutics Market Estimate by Market Segment
           7.3.3. North America Metabolic Disorder Therapeutics Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Metabolic Disorder Therapeutics Market Estimate by Market Segment
           7.4.3. Europe Metabolic Disorder Therapeutics Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Metabolic Disorder Therapeutics Market Estimate by Market Segment
           7.5.3. Asia Pacific Metabolic Disorder Therapeutics Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Metabolic Disorder Therapeutics Market Estimate by Market Segment
           7.6.3. Latin America Metabolic Disorder Therapeutics Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Metabolic Disorder Therapeutics Market Estimate by Market Segment
           7.7.3. Middle East & Africa Metabolic Disorder Therapeutics Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE METABOLIC DISORDER THERAPEUTICS COMPANIES
       8.1. Metabolic Disorder Therapeutics Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF METABOLIC DISORDER THERAPEUTICS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. AbbVie Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Actelion Pharmaceuticals Ltd.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. AstraZeneca
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Biocon
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Boehringer Ingelheim
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. CymaBay Therapeutics
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Eli Lilly and Company
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Merck KgaA
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Novo Nordisk
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Sanofi
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Metachromatic Leukodystrophy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Globoid Leukodystrophy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Hepatic Encephalopathy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Others by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis by By Disease (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Diabetes by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Obesity by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Hypercholesterolemia by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Lysosomal Storage Diseases by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market by Geography (USD MN)
  • North America Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • North America Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • North America Metabolic Disorder Therapeutics Market Estimate by Country (USD MN)
  • United State Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • United State Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Rest of North America Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Rest of North America Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Europe Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Europe Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • United Kingdom Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • United Kingdom Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • France Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • France Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Germany Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Germany Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Rest of Europe Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Rest of Europe Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Asia Pacific Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Asia Pacific Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Asia Pacific Metabolic Disorder Therapeutics Market Estimate by Country (USD MN)
  • China Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • China Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Japan Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Japan Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • India Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • India Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Rest of Asia Pacific Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Rest of Asia Pacific Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Latin America Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Latin America Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Latin America Metabolic Disorder Therapeutics Market Estimate by Country (USD MN)
  • Brazil Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Brazil Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Rest of Latin America Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Rest of Latin America Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Middle East & Africa Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Middle East & Africa Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Middle East & Africa Metabolic Disorder Therapeutics Market Estimate by Country (USD MN)
  • Middle East Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Middle East Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Africa Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Africa Metabolic Disorder Therapeutics Market Estimate by By Disease (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  • Research Scope of Metabolic Disorder Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Metabolic Disorder Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by By Product
  • Market Attractiveness Analysis by By Disease
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Metabolic Disorder Therapeutics Market Analysis by By Product (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Metachromatic Leukodystrophy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Globoid Leukodystrophy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Hepatic Encephalopathy by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Others by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis by By Disease (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Diabetes by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Obesity by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Hypercholesterolemia by Geography (USD MN)
  • Global Metabolic Disorder Therapeutics Market Analysis in Lysosomal Storage Diseases by Geography (USD MN)
  • Latin America Metabolic Disorder Therapeutics Market by Revenue
  • Middle East & Africa Metabolic Disorder Therapeutics Market by Revenue
  • Recent Development in Metabolic Disorder Therapeutics Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials